Predicting breast cancer therapeutic response

被引：0
|
作者：
Ana C. Garrido-Castro
Eric P. Winer
机构：
[1] Dana-Farber Cancer Institute,Department of Medical Oncology
来源：
Nature Medicine | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In triple-negative breast cancer, therapeutic response to carboplatin and docetaxel is similar. However, carboplatin therapy is superior to docetaxel in patients with germline BRCA1 or BRCA2 mutations, but ‘BRCAness’ does not predict sensitivity to carboplatin. 
引用
收藏
页码：535 / 537
页数：2
相关论文
共 50 条
  • [1] Predicting breast cancer therapeutic response
    Garrido-Castro, Ana C.
    Winer, Eric P.
    NATURE MEDICINE, 2018, 24 (05) : 535 - 537
  • [2] Predicting response to therapy in breast cancer
    Van de Vijver, M.
    EJC SUPPLEMENTS, 2010, 8 (05): : 162 - 162
  • [3] Identification of an immune classifier for predicting the prognosis and therapeutic response in triple-negative breast cancer
    Lin, Kuailu
    Gu, Qianyu
    Lai, Xixi
    BIOCELL, 2023, 47 (12) : 2681 - 2696
  • [4] Predicting response to primary chemotherapy in breast cancer
    Schofield, AC
    Pavlidou, E
    Miller, ID
    Spyrantis, A
    Hutcheon, AW
    Heys, SD
    BRITISH JOURNAL OF SURGERY, 2003, 90 (05) : 626 - 627
  • [5] Breast cancer and predictive factors in therapeutic response
    Ravaud, A.
    BULLETIN DU CANCER, 2011, 98 : S64 - S64
  • [6] Histological assessment of therapeutic response in breast cancer
    Rie Horii
    Futoshi Akiyama
    Breast Cancer, 2016, 23 : 540 - 545
  • [7] Histological assessment of therapeutic response in breast cancer
    Horii, Rie
    Akiyama, Futoshi
    BREAST CANCER, 2016, 23 (04) : 540 - 545
  • [8] A lactate-related LncRNA model for predicting prognosis, immune landscape and therapeutic response in breast cancer
    Li, Jia
    Zhang, Yinbin
    Li, Chaofan
    Wu, Huizi
    Feng, Cong
    Wang, Weiwei
    Liu, Xuan
    Zhang, Yu
    Cai, Yifan
    Jia, Yiwei
    Qiao, Hao
    Wu, Fei
    Zhang, Shuqun
    FRONTIERS IN GENETICS, 2022, 13
  • [9] Predicting response/resistance to endocrine therapy for breast cancer
    Miller, WR
    Anderson, TJ
    Evans, D
    Krause, A
    Dixon, JM
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S5 - S6
  • [10] Predicting epirubicin response in Danish patients with breast cancer
    Buhl, Ida Kappel
    Nart, Jan
    Papadovasilakis, Zacharias
    Sorensen, Simon
    Jensen, Peter Buhl
    Ejlertsen, Bent
    Buhl, Ulla Hald
    Tsamardinos, Ioannis
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345